Andersons pediatric cardiology 1106
Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (78.52 KB, 3 trang )
CardiovascInterv.2015;86:249–257.
212.SantoroG,GaioG,CapozziG,etal.Fateof
hypoplasticpulmonaryarteriesafterarterialduct
stentingincongenitalheartdiseasewithDuctdependentpulmonarycirculation.JACC
CardiovascInterv.2015;8:1626–1632.
213.AlwiM,ChooKK,LatiffHA,etal.Initial
resultsandmedium-termfollow-upofstent
implantationofpatentductusarteriosusinductdependentpulmonarycirculation.JAmColl
Cardiol.2004;44:438–445.
214.LeeKJ,HinekA,ChaturvediRR,etal.
Rapamycin-elutingstentsinthearterialduct:
experimentalobservationsinthepigmodel.
Circulation.2009;119(15):2078–2085.
215.LeeKJ,SetoW,BensonL,ChaturvediRR.
Pharmacokineticsofsirolimus-elutingstents
implantedintheneonatalarterialduct.Circ
CardiovascInterv.2015;8:e002233.
216.SchubertS,PetersB,BergerF.InterventionalreopeningofaPDAforreversepottsshunt
circulationafterADOIimplantationinachild.
CatheterCardiovascInterv.2017;89:E133–
E136.
217.LatusH,ApitzC,MoysichA,etal.Creationofa
functionalpottsshuntbystentingthepersistent
arterialductinnewbornsandinfantswith
suprasystemicpulmonaryhypertensionof
variousetiologies.JHeartLungTransplant.
2014;33:542–546.
218.BoudjemlineY,PatelM,Malekzadeh-MilaniS,
etal.Patentductusarteriosusstenting
(transcatheterpottsshunt)forpalliationof
suprasystemicpulmonaryarterialhypertension:
acaseseries.CircCardiovascInterv.
2013;6:e18–e20.
219.MasonCA,BigrasJL,O'BlenesSB,etal.Gene
transferinuterobiologicallyengineersapatent
ductusarteriosusinlambsbyarresting
fibronectin-dependentneointimalformation.Nat
Med.1991;5:176–182.
220.RajotteD,ArapW,HagedornM,etal.
Molecularheterogeneityofthevascular
endotheliumrevealedbyinvivophagedisplay.J
ClinInvest.1998;102:430–437.
221.HumplT,ZaidiSH,CoeJY,etal.Genetransfer
ofprostaglandinsynthasemaintainspatencyof
thenewbornlambarterialduct.PediatrRes.
2005;58:976–980.
42
